Expert consensus on standardized management of tumor gene sequencing for cancer patients
Abstract Background Tumour gene detection by next‐generation sequencing (NGS) can comprehensively analyze the molecular characteristics of tumors, and predict drug efficacy and tumor resistance mechanisms through tumour cell models, thereby realizing individualized and precise treatment. Therefore,...
Main Authors: | Mengjia Qian, Yanxia Zhan, Lili Ji, Hao Chen, Yunfeng Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.216 |
Similar Items
-
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
by: Xuchao Zhang, et al.
Published: (2019-03-01) -
Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data
by: Shifu Chen, et al.
Published: (2019-12-01) -
Expert consensus on population-based BRCA germline mutation screening in China (2024 edition)
by: China Anti-Cancer Association Tumor Biomarker Professional Committee, Shanghai Anti-Cancer Association Tumor Biomarker Professional Committee
Published: (2024-02-01) -
Metagenomic Next-generation Sequencing: Current Status, Challenges and Prospects of Clinical Application
by: DIAO Zhenli, et al.
Published: (2023-09-01) -
OGC Consensus: How Successful Standards Are Made
by: Carl Reed, et al.
Published: (2015-09-01)